Flexomics

Screening platform for single-cell genomics

Flexomics is simplifying and accelerating the development of high-value biologics. Currently, there is a need for a rapid and cost effective solution to identify and optimize high-value biologics. Using their proprietary platform, Flexomics is performing large-scale simultaneous functional and genomic analyses of single cells and cell-to-cell interactions. Through harvesting the information inherent to biological diversity, Flexomics is developing the next generation of personalized treatments.